Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03323021 · ClinicalTrials.gov registry record · NA
Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy
A NA study, sponsored by MiMedx Group.
- Completed
- Registry status
- NA
- Development phase
- 61
- Enrollment target
NCT03323021 is a NA study that has completed, run by MiMedx Group. The registered enrollment target is 61 participants.
The verdict
NCT03323021, a NA study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- NA
- Development phase
- 61 participants
- Enrollment target
Study Summary
After partial nephrectomy, kidney function decreases by about 10% overall and by about 20% in the operated kidney. This is primarily due to the loss of healthy parenchymal volume during resection of the tumor. In an effort to preserve and regenerate healthy parenchyma during the procedure and ultimately renal function after partial nephrectomy, the single center double arm single-blinded randomized screening clinical trial will evaluate the ability of human amnion/chorion allograft to facilitate the recovery of renal function following robotic partial nephrectomy.
Interventions
- OTHER Standard of Care
- OTHER Dehydrated human amnion/chorion membrane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2017-05-23 |
| Est. Completion | 2019-02-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03323021
The ClinicalTrials.gov registry entry for NCT03323021 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 61 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Standard of Care is the first listed.
NCT03323021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03323021 about?
NCT03323021 is a clinical study titled "Use of Human Dehydrated Amnion/Chorion (DHACM) Allograft in Partial Nephrectomy". After partial nephrectomy, kidney function decreases by about 10% overall and by about 20% in the operated kidney. This is primarily due to the loss of healthy parenchymal volume during resection of the tumor. In an effort to preserve and regenerate healthy parenchyma during the procedure and ultima...
What is the current status of trial NCT03323021?
This trial is currently completed. It is a NA study. The enrollment target is 61 participants. The study started on 2017-05-23. Estimated completion is 2019-02-21.
What interventions are being tested in trial NCT03323021?
The interventions under investigation include: Standard of Care (OTHER), Dehydrated human amnion/chorion membrane (OTHER).
Who is sponsoring clinical trial NCT03323021?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.